368 related articles for article (PubMed ID: 17332843)
1. Is the prevalence of overactive bladder overestimated? A population-based study in Finland.
Tikkinen KA; Tammela TL; Rissanen AM; Valpas A; Huhtala H; Auvinen A
PLoS One; 2007 Feb; 2(2):e195. PubMed ID: 17332843
[TBL] [Abstract][Full Text] [Related]
2. Understanding the elements of overactive bladder: questions raised by the EPIC study.
Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study.
Vaughan CP; Johnson TM; Ala-Lipasti MA; Cartwright R; Tammela TL; Taari K; Auvinen A; Tikkinen KA
Eur Urol; 2011 Apr; 59(4):629-36. PubMed ID: 21306820
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
[TBL] [Abstract][Full Text] [Related]
6. Nocturia and obesity: a population-based study in Finland.
Tikkinen KA; Auvinen A; Huhtala H; Tammela TL
Am J Epidemiol; 2006 Jun; 163(11):1003-11. PubMed ID: 16597705
[TBL] [Abstract][Full Text] [Related]
7. Lower urinary tract symptoms: lack of change in prevalence and help-seeking behaviour in two population-based surveys of women in 1991 and 2007.
Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
BJU Int; 2009 Oct; 104(7):954-9. PubMed ID: 19388983
[TBL] [Abstract][Full Text] [Related]
8. A population-based study of urinary symptoms and incontinence: the Canadian Urinary Bladder Survey.
Herschorn S; Gajewski J; Schulz J; Corcos J
BJU Int; 2008 Jan; 101(1):52-8. PubMed ID: 17908260
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and burden of overactive bladder in the United States.
Stewart WF; Van Rooyen JB; Cundiff GW; Abrams P; Herzog AR; Corey R; Hunt TL; Wein AJ
World J Urol; 2003 May; 20(6):327-36. PubMed ID: 12811491
[TBL] [Abstract][Full Text] [Related]
10. Is nocturia equally common among men and women? A population based study in Finland.
Tikkinen KA; Tammela TL; Huhtala H; Auvinen A
J Urol; 2006 Feb; 175(2):596-600. PubMed ID: 16407003
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and correlation of urinary incontinence and overactive bladder in Taiwanese women.
Chen GD; Lin TL; Hu SW; Chen YC; Lin LY
Neurourol Urodyn; 2003; 22(2):109-17. PubMed ID: 12579627
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiological aspects of nocturia in a danish population of men and women age 60 to 80 years.
Bing MH; Moller LA; Jennum P; Mortensen S; Lose G
J Urol; 2007 Aug; 178(2):552-7. PubMed ID: 17570415
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.
Wang Y; Xu K; Hu H; Zhang X; Wang X; Na Y; Kang X
Neurourol Urodyn; 2011 Nov; 30(8):1448-55. PubMed ID: 21826714
[TBL] [Abstract][Full Text] [Related]
14. Urgency is the core symptom of female overactive bladder syndrome, as demonstrated by a statistical analysis.
Hung MJ; Ho ES; Shen PS; Sun MJ; Lin AT; Chen GD;
J Urol; 2006 Aug; 176(2):636-40. PubMed ID: 16813910
[TBL] [Abstract][Full Text] [Related]
15. Urinary incontinence and overactive bladder in patients with heart failure.
Palmer MH; Hardin SR; Behrend C; Collins SK; Madigan CK; Carlson JR
J Urol; 2009 Jul; 182(1):196-202. PubMed ID: 19447424
[TBL] [Abstract][Full Text] [Related]
16. Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45-103 years.
Malmsten UG; Molander U; Peeker R; Irwin DE; Milsom I
Eur Urol; 2010 Jul; 58(1):149-56. PubMed ID: 20356669
[TBL] [Abstract][Full Text] [Related]
17. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
[TBL] [Abstract][Full Text] [Related]
19. Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.
Rovner ES; Kreder K; Sussman DO; Kaplan SA; Carlsson M; Bavendam T; Guan Z
J Urol; 2008 Sep; 180(3):1034-41. PubMed ID: 18639297
[TBL] [Abstract][Full Text] [Related]
20. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
